Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nucana Plc ADR (NCNA)

Nucana Plc ADR (NCNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nucana Plc ADR 3 Lochside Way Edinburgh X0 EH12 9DT GBR

www.nucana.com P: 44-0-13-1357-1111

Description:

NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in EDINBURGH, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 9,092
Enterprise Value, $K -12,338
Shares Outstanding, K 2,643
Annual Sales, $ 0 K
Annual Net Income, $ -34,370 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,830 K
EBIT, $ -42,360 K
EBITDA, $ -41,640 K
60-Month Beta 1.01
% of Insider Shareholders 31.20%
% of Institutional Shareholders 44.00%
Float, K 1,818
% Float 68.80%
Short Volume Ratio 0.24

Growth:

1-Year Return -80.82%
3-Year Return -94.27%
5-Year Return -98.10%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -15.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.79 on 08/15/24
Next Earnings Date 08/21/24
Earnings Per Share ttm -12.20
EPS Growth vs. Prev Qtr -2,268.75%
EPS Growth vs. Prev Year -16.62%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 04/16/24

NCNA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -222.73%
Return-on-Assets % -105.63%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.51
Book Value/Share 1.82
Interest Coverage -3.88
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar